Cited by CrossRef (38)
- Carmela Dell’Aversana, Cristina Giorgio, Francesco Paolo Tambaro, Giulia Sgueglia, Lucia Altucci. Medical Epigenetics. .
- Alice Moncada, Alessandro Pancrazzi. Cellular and Molecular Aspects of Myeloproliferative Neoplasms – Part B. .
- Ayad M. Ali, Gaza F. Salih. Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia. Mol Biol Rep 2022;49:11685
- Kun Yao, Hua Liu, Shui Yu, Haohao Zhu, Jie Pan. Resistance to mutant IDH inhibitors in acute myeloid leukemia: Molecular mechanisms and therapeutic strategies. Cancer Letters 2022;533:215603
- Taha Bahsi, Ezgi Cevik, Zeynep Ozdemir, Haktan Bagis Erdem. Cancer Epigenetics. 2022.
- Andrew Hindley, Mark Alexander Catherwood, Mary Frances McMullin, Ken I. Mills. Significance of NPM1 Gene Mutations in AML. IJMS 2021;22:10040
- Ailin Zhao, Hui Zhou, Jinrong Yang, Meng Li, Ting Niu. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Sig Transduct Target Ther 2023;8
- Srishti Mishra, Jun Liu, Li Chai, Daniel G. Tenen. Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance. 2022;29:34
- Seo-Gyeong Bae, Hyeoung-Joon Kim, Mi Yeon Kim, Dennis Dong Hwan Kim, So-I Shin, Jae-Sook Ahn, Jihwan Park. Identification of Cell Type-Specific Effects of DNMT3A Mutations on Relapse in Acute Myeloid Leukemia. Molecules and Cells 2023;46:611
- Louise Pettersson, Benjamin Holmgren, Gunnar Juliusson, Vladimir Lj Lazarevic, Mats Ehinger. Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years. Leukemia & Lymphoma 2021;62:1958
- Алексина Алексеевна Шатилова, И. Г. Будаева, А. В. Петухов, С. А. Силонов, А. Е. Ершова, Т. С. Никулина, Ю. Д. Матвиенко, Ю. В. Миролюбова, К. В. Богданов, Л. В. Анчукова, Ю. С. Нередько, С. Ю. Тяско, О. Е. Очирова, А. Г. Карпова, Э. Р. Васильева, О. Д. Сердюк, Д. А. Яскульский, Д. В. Букин, Ю. А. Алексеева, Е. Г. Ломаиа, Л. Л. Гиршова. Прогностическое значение соматических мутаций в генах эпигенетической регуляции при острых миелоидных лейкозах в реальной клинической практике: результаты наблюдательного неинтервенционного проспективного межрегионального исследования. Clinical Oncohematology 2024;16:174
- Qian Wu, Anusha Sriraman, Turja K. Debnath, Blerta Xhemalce, Kyle M. Miller. Making it or breaking it: DNA methylation and genome integrity. 2020;64:687
- T. N. Subbotina, I. E. Maslyukova, K. S. Semashchenko, G. A. Khodos, D. V. Kurochkin, A. A. Shalyova, M. A. Mikhalev, E. V. Vasiliev, M. G. Osadchaya, E. A. Dunaeva, A. S. Esman, K. O. Mironov. Analysis of somatic mutations in the JAK2, CALR, MPL and ASXL1 genes and evaluation of their impact on the survival of patients with myelofibrosis. Onkogematologiâ 2023;18:63
- Isaiah K Mensah, Allison B Norvil, Lama AlAbdi, Sarah McGovern, Christopher J Petell, Ming He, Humaira Gowher. Misregulation of the expression and activity of DNA methyltransferases in cancer. 2021;3
- Yongfeng Chen, Jing Li, Linglong Xu, Mihnea-Alexandru Găman, Zhenyou Zou. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting. Cell Death Discov. 2022;8
- Kimberley Doucette, Judith Karp, Catherine Lai. Advances in therapeutic options for newly diagnosed, high-risk AML patients. Therapeutic Advances in Hematology 2021;12:204062072110011
- Lenka Kalinkova, Aneta Sevcikova, Viola Stevurkova, Ivana Fridrichova, Sona Ciernikova. Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool. IJMS 2022;24:633
- Peggy Kanellou, Ilias Georgakopoulos-Soares, Apostolos Zaravinos. Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients. Cancers 2023;15:1795
- Jaimie S. Gray, Sajad A. Wani, Moray J. Campbell. Epigenomic alterations in cancer: mechanisms and therapeutic potential. 2022;136:473
- Cynthia A. Schandl, Sandra Mazzoni, Iya Znoyko, Georges J. Nahhas, Dongjun Chung, Yanna Ding, Brian Hess, Daynna J. Wolff. Novel high–risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53. Cancer Genetics 2023;272-273:23
- Guadalupe Oñate, Alex Bataller, Ana Garrido, Montserrat Hoyos, Montserrat Arnan, Susana Vives, Rosa Coll, Mar Tormo, Antònia Sampol, Lourdes Escoda, Olga Salamero, Antoni Garcia, Joan Bargay, Alba Aljarilla, Josep F. Nomdedeu, Jordi Esteve, Jorge Sierra, Marta Pratcorona. Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
. 2022;6:882
- Lirong Nie, Yuming Zhang, Yuchan You, Changmei Lin, Qinghua Li, Wenbo Deng, Jingzhi Ma, Wenying Luo, Honghua He. The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients. Hematology 2022;27:833
- Marion Wobser, Sabine Roth, Silke Appenzeller, Hermann Kneitz, Matthias Goebeler, Eva Geissinger, Andreas Rosenwald, Katja Maurus. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innovations 2021;1:100034
- Marcus A. Florez, Brandon T. Tran, Trisha K. Wathan, James DeGregori, Eric M. Pietras, Katherine Y. King. Clonal hematopoiesis: Mutation-specific adaptation to environmental change. Cell Stem Cell 2022;29:882
- Naoki Miyashita, Masahiro Onozawa, Shota Yoshida, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Akio Mori, Shuichi Ota, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Makoto Ibata, Kentaro Wakasa, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Takeshi Kondo, Takanori Teshima. Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study. Int J Hematol 2023;118:36
- Mihee Kim, TaeHyung Kim, Seo-Yeon Ahn, Jun Hyung Lee, Ju Heon Park, Myung-Geun Shin, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Mi Yeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim. The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine. Korean J Intern Med 2023;38:534
- Sorina Mihaela Papuc, Alina Erbescu, Diana Cisleanu, Diana Ozunu, Cristina Enache, Ion Dumitru, Elena Lupoaia Andrus, Mihaela Gaman, Viola Maria Popov, Maria Dobre, Oana Stanca, Silvana Angelescu, Nicoleta Berbec, Andrei Colita, Ana-Maria Vladareanu, Horia Bumbea, Aurora Arghir. Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies. Genes 2021;12:846
- Sangeetha Sampath, Pratibha Misra, Sandeep Kumar Yadav, Sanjeevan Sharma, Venkatesan Somasundaram. A study on DNA methylation status in promoter region of p15 gene in patients of acute myeloid leukemia and myelodysplastic syndrome. Medical Journal Armed Forces India 2021;77:337
- Moon Nyeo Park. The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients. IJMS 2023;24:12037
- Xiaoxuan Lai, Jinyan Xiao, Tanzhen Wang, Chang Hou, Jia Chen, Depei Wu, Yang Xu. Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission. Leukemia & Lymphoma 2024;65:363
- Aysun Adan. . 2024.
- Yanfen Li, Hua Wan, Yu Jing. Molecular Characterization and Clinical Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Patients With TP53 Mutation. Clinical Lymphoma Myeloma and Leukemia 2021;21:841
- V. P. Maksimova, O. G. Usalka, Yu. V. Makus, V. G. Popova, E. S. Trapeznikova, G. I. Khayrieva, G. R. Sagitova, E. M. Zhidkova, A. Yu. Prus, M. G. Yakubovskaya, K. I. Kirsanov. Aberrations of DNA methylation in cancer. Usp. mol. onkol 2022;9:24
- Weijing Li, Shuguang Liu, Chanjuan Wang, Lei Cui, Xiaoxi Zhao, Wei Liu, Ruidong Zhang, Zhigang Li. DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells. BMC Cancer 2023;23
- Ayad M. Ali, Gaza F. Salih. Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients. Mol Biol Rep 2023;50:8035
- Bailey M. Tibben, Scott B. Rothbart. Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation. Journal of Molecular Biology 2024;436:168394
- Alvina I. Khamidullina, Ekaterina A. Varlamova, Nour Alhuda Hammoud, Margarita A. Yastrebova, Alexandra V. Bruter. Gene Transcription as a Therapeutic Target in Leukemia. IJMS 2021;22:7340
- Sumana Choudhury, Anuhya Anne, Minali Singh, John Richard Chaillet, Kommu Naga Mohan. DNMT1 Y495C mutation interferes with maintenance methylation of imprinting control regions. The International Journal of Biochemistry & Cell Biology 2024;169:106535